Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The state has the lowest proportion of teens who have received the cancer-preventing HPV vaccine.
Part 2 in a series from the University of Colorado that unpacks the goals of the National Cancer Institute’s National Cancer Plan.
Cancer survivors make awesome advocates, and the summer 2023 issue of Cancer Health profiles several inspiring figures.
Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.
Human papillomavirus, a common sexually transmitted infection, can cause cervical, anal, and oral cancers.
Vaccines could potentially eliminate cervical, anal, oral and other cancers caused by human papillomavirus.
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should long COVID surprise us?
Antonio Jimeno, MD, PhD, led research studying a cell squeezing process used to treat a subtype of HPV16-driven head and neck cancer.
Andy Taylor, Tim Commerford, Jamie Raskin and Martina Navratilova make cancer headlines.
ACS launches initiative to address prostate cancer resurgence and racial disparities.
The tennis star’s HPV-related throat cancer could be related to her previous breast cancer, says Jessica McDermott, MD.
“This double whammy is serious but still fixable,” said tennis legend Martina Navratilova, who was treated for breast cancer in 2010.
Black and Latino men with HPV-associated throat cancer experience worse outcomes—including higher death rates—than white men.
A partnership to prevent human papillomavirus cancers maintained and even grew HPV vaccination rates for 9- to 13-year-olds.
Early vaccination reduces the risk of cervical cancer by nearly 90%, but many young people remain unprotected.
A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.